Lactated Ringer's solution for preventing myocardial reperfusion injury

Area of Science:

• Cardiovascular Medicine
• Ischemic Heart Disease
• Regenerative Medicine

Background:

• Reperfusion is vital for salvaging ischemic myocardium but paradoxically causes reperfusion injury.
• Reperfusion injury encompasses stunned myocardium, arrhythmias, microvascular damage, and lethal injury, with no current clinical prevention.
• ST-segment elevation myocardial infarction (STEMI) patients are particularly vulnerable to these detrimental effects.

Purpose of the Study:

• To introduce and review a novel postconditioning protocol, postconditioning with lactate-enriched blood (PCLeB).
• To elucidate the mechanism of reperfusion injury and how PCLeB targets it.
• To report the efficacy of PCLeB in preventing all types of reperfusion injury in STEMI patients.

Main Methods:

• PCLeB involves intermittent reperfusion and coronary injections of lactated Ringer's solution.
• The protocol aims for controlled reperfusion, enhanced cellular oxygenation, and minimized lactate washout.
• Review of clinical data and outcomes in STEMI patients treated with PCLeB.

Main Results:

• PCLeB demonstrated effectiveness in preventing all forms of reperfusion injury.
• Excellent in-hospital outcomes were observed in STEMI patients treated with this approach.
• The mechanism of action targets a validated pathway of reperfusion injury.

Conclusions:

• PCLeB represents a promising strategy for mitigating reperfusion injury in STEMI.
• This controlled reperfusion method offers significant clinical benefits.
• Further investigation into PCLeB's long-term effects and broader applications is warranted.